WHA73

Due to the COVID-19 pandemic, the World Health Organization (WHO) hosted the annual World Health Assembly (WHA) virtually for the first time in history. This two-day virtual convening took place on May 18-19, 2020 and focused on an abbreviated agenda of items essential for governance business continuity and COVID-19. This page is a collection of our activities at the 73rd WHA (WHA73).

WHA73 Statement

Global Health Council, and our delegation of more than 35 members from 11 countries including 7 low- and middle-income countries, submitted a statement to WHO at WHA73. The statement applauds WHO on its COVID-19 response and calls for the following in order to overcome the COVID-19 pandemic:

  • do no harm;
  • put the wellbeing of citizens first;
  • protect human rights and vulnerable populations;
  • provide equitable access to new COVID-19 drugs, vaccines, diagnostics, and other health
    products;
  • invest in all levels of the health system, particularly at the community level;
  • ensure access to evidence-based, quality health interventions;
  • be guided by peer-reviewed research and devoid of political influence;
  • be transparent, accountable, and participatory;
  • support solidarity, coordination, and resource sharing;
  • catalyze greater compliance with international health regulations;
  • ensure universal health coverage by 2030 for a more equitable world, safe from pandemic
    threats.

Click to read the full statement.

The Evolution of Public-Private Partnerships amidst a Pandemic

On May 21, alongside WHA73, GHC hosted a discussion on the role of public-private partnerships during the COVID-19 pandemic. This session featured on-the-ground accounts of what has worked in the immediate term and how those activities might inform improvements for these collaborations moving forward.

Featured Speakers:  Bobby Jefferson, Vice President, Chief Technology Officer, DAI Global Health; Dr. Susan Mukasa, Vice President, Anglophone Africa, PSI; Courtney Roberts, Director, Global Health Philanthropic Partnerships, Eli Lilly & Company; Sylvana Sinha, Founder & CEO, Praava Health; Dr. Patrick Osewe, Chief, Health Sector Group, Asian Development Bank; Trey Watkins, Senior Vice President, Global Health & Corporate Responsibility, GCI Health

Civil Society Town Hall with WHO DG Dr. Tedros

On May 26, GHC co-organized a Civil Society Town Hall with WHO Director-General (DG) Dr. Tedros Adhanom Ghebreyesus and leaders from the global health community from across the world. This closed-door virtual event was co-organized with Action for Global Health, RESULTS, Civil Society Engagement Mechanism for UHC 2030, and WACI Health and brought together over 130 civil society leaders from across 33 countries to discuss the role of civil society in the COVID-19 response.

During the town hall, Dr. Tedros committed to more regular engagement and invited civil society leaders to the table to discuss solutions noting, "It is the empowerment of communities and civil society that will help in defeating COVID.”

Featured speakers: Loyce Pace, President & Executive Director, Global Health Council; Esther Njoroge, Advisory Group Member, CSEM for UHC2030; Dr. Tedros, DG, WHO; Katie Husselby, Coordinator, Action for Global Health; and Rosemary Mburu, Executive Director, WACI Health